Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
Includes bibliographical references (leaves 190-203).
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of Clinical Pharmacology
2014
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
- A critical appraisal of the clinical pharmacokinetics of isoniazid
- The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
- Variability in the pharmacokinetics of rifapentine in South African tuberculosis patients : a classical and population approach
- The therapeutic importance of isoniazid metabolism in elderly patients
- Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment